)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Bio-Gate
Bio-Gate (BIG) investor relations material
Bio-Gate H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary9 Oct, 2026
Executive summary
H1 revenue fell 17.7% YoY to €2.828m as portfolio and organizational changes at two major customers reduced orders; cost reductions limited the impact on earnings.
Net loss after minority interests widened to €988k; EBITDA loss was €814k.
Reorganization and August equity raises are intended to strengthen the cost base and financing; FY2026 guidance was lowered, with recovery toward 2025 levels targeted for 2027.
Financial highlights
H1 revenue was €2,828k versus €3,435k; EBITDA loss was €814k versus €723k, and EBIT loss was €927k versus €840k.
Net loss after minority interests widened to €988k from €836k; interest expense rose to €59k from €31k.
Material costs fell to €1,083k from €1,381k and personnel costs to €1,481k from €1,558k; other operating expenses rose 4.6% to €1,254k.
Operating cash flow was -€663k versus -€614k; period-end cash was €78k versus €705k at Dec. 31, 2025.
Outlook and guidance
FY2026 revenue guidance was reduced to €6.0m–€6.9m from €6.9m–€7.9m; EBITDA is forecast at -€0.9m to -€1.1m and EBIT at -€1.1m to -€1.5m.
Revenue is expected to return toward 2025 levels in 2027, conditional on development projects avoiding major delays and planned commercialization being achieved.
Scar-treatment medical product deliveries for a major skincare customer are expected from early 2027; existing animal-care products are planned to transition into a new product line.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bio-Gate
- Revenue up 4.9% to €7.4M; improved EBITDA; liquidity sufficient for 2026, but risks persist.BIG
H2 2025 - Revenue up 9% year-over-year, but losses widened; strong outlook for 2024 maintained.BIGH1 2024
- Revenue fell, losses persisted, and liquidity tightened, but 2025 improvement is expected.BIGH2 2024
- EBITDA and net loss improved despite lower revenue; strong outlook for 2025.BIGH1 2025
Next Bio-Gate earnings date
H2 202619 May, 2027
Bio-Gate
Next Bio-Gate earnings date
H2 202619 May, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)